Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
26 Apr 24
8-K
BioMarin Reports Record Financial Results for the First Quarter 2024
24 Apr 24
8-K
Other Events
23 Apr 24
ARS
2023 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
10-K
2023 FY
Annual report
26 Feb 24
8-K
BioMarin Reports Record Financial Results for the Fourth Quarter and Full-year 2023 and Provides Financial Guidance for 2024
22 Feb 24
8-K
Departure of Directors or Certain Officers
11 Jan 24
8-K
BioMarin Announces Governance Enhancements and Value Creation Initiatives
20 Dec 23
8-K
Departure of Directors or Certain Officers
3 Nov 23
S-8
Registration of securities for employees
2 Nov 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
8-K
BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over Year
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
8-K
Results of Operations and Financial Condition
31 Jul 23
8-K
Departure of Directors or Certain Officers
30 May 23
10-Q
2023 Q1
Quarterly report
28 Apr 23
8-K
BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues
26 Apr 23
ARS
2022 FY
Annual report to shareholders
11 Apr 23
DEFA14A
Additional proxy soliciting materials
11 Apr 23
DEF 14A
Definitive proxy
11 Apr 23
UPLOAD
Letter from SEC
10 Apr 23
CORRESP
Correspondence with SEC
6 Apr 23
UPLOAD
Letter from SEC
30 Mar 23
10-K
2022 FY
Annual report
27 Feb 23
8-K
Results of Operations and Financial Condition
27 Feb 23
8-K
Results of Operations and Financial Condition
11 Jan 23
8-K
Amendments to Articles of Incorporation or Bylaws
21 Dec 22
10-Q
2022 Q3
Quarterly report
28 Oct 22
8-K
Results of Operations and Financial Condition
26 Oct 22
8-K
Cost Associated with Exit or Disposal Activities
6 Oct 22
8-K
Regulation FD Disclosure
12 Sep 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
8-K
BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance
3 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
31 May 22
8-K
Departure of Directors or Certain Officers
5 May 22
10-Q
2022 Q1
Quarterly report
29 Apr 22
8-K
BioMarin Announces Record Revenues in First Quarter 2022
27 Apr 22
DEFA14A
Additional proxy soliciting materials
12 Apr 22
Latest ownership filings
4
JEAN JACQUES BIENAIME
15 Apr 24
4
Erin Burkhart
12 Apr 24
144
Notice of proposed sale of securities
12 Apr 24
144
Notice of proposed sale of securities
11 Apr 24
144
Notice of proposed sale of securities
10 Apr 24
4
George Eric Davis
1 Apr 24
144
Notice of proposed sale of securities
28 Mar 24
4
Dennis Slamon
20 Mar 24
4
Erin Burkhart
19 Mar 24
4
George Eric Davis
19 Mar 24
4
Charles Greg Guyer
19 Mar 24
4
Brian Mueller
19 Mar 24
4
HENRY J FUCHS
19 Mar 24
4
Alexander Hardy
19 Mar 24
4
JEAN JACQUES BIENAIME
19 Mar 24
4
Jeffrey Robert Ajer
19 Mar 24
4
HENRY J FUCHS
7 Mar 24
4
JEAN JACQUES BIENAIME
7 Mar 24
4
Jeffrey Robert Ajer
7 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
144
Notice of proposed sale of securities
5 Mar 24
4
Brian Mueller
29 Feb 24
4
George Eric Davis
29 Feb 24
4
Charles Greg Guyer
29 Feb 24
4
Jeffrey Robert Ajer
29 Feb 24
4
HENRY J FUCHS
29 Feb 24
4
JEAN JACQUES BIENAIME
29 Feb 24
144
Notice of proposed sale of securities
27 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
DODGE & COX
13 Feb 24
4
JEAN JACQUES BIENAIME
12 Feb 24
SC 13G/A
PRIMECAP MANAGEMENT CO/CA/
12 Feb 24
5
JEAN JACQUES BIENAIME
12 Feb 24
5
Brian Mueller
12 Feb 24
SC 13G
Capital Research Global Investors
9 Feb 24
144
Notice of proposed sale of securities
9 Feb 24
144
Notice of proposed sale of securities
8 Feb 24
SC 13G/A
BlackRock Inc.
26 Jan 24